Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

596
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
596
Survival Tree01:19

Survival Tree

499
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
499
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

955
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
955
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
Hazard Ratio01:12

Hazard Ratio

756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
756

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From manual entry to machine precision: challenges and evolution of metadata schema development in collaborative research centers.

BMC research notes·2026
Same author

LLMs for Healthcare Process Orchestration: Promises and Challenges.

Studies in health technology and informatics·2026
Same author

Challenges of Bringing Augmented Reality into Nursing Medication Preparation.

Studies in health technology and informatics·2026
Same author

Modeling Blood Pressure Monitoring in openEHR: An Implementation Case Study.

Studies in health technology and informatics·2026
Same author

Modeling Reimbursement-Relevant Drug Data as a Property Graph.

Studies in health technology and informatics·2026
Same author

LLMs in Problem-Based Learning: The Grounding Issue.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: May 2, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K

Combining techniques for screening and evaluating interaction terms on high-dimensional time-to-event data.

Murat Sariyar1, Isabell Hoffmann, Harald Binder

  • 1Institute of Medical Biostatistics, Epidemiology and Informatics, Medical Center of the Johannes Gutenberg University, Mainz 55131, Germany. murat.sariyar@charite.de.

BMC Bioinformatics
|February 28, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces methods to identify gene interactions for predicting patient survival from high-dimensional molecular data. Combining techniques like random forests improves detection of relevant interactions, even when computationally challenging.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K

Related Experiment Videos

Last Updated: May 2, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Statistical Genetics

Background:

  • High-dimensional molecular data, such as from microarrays, is crucial for predicting patient survival.
  • Existing multivariate risk prediction models integrate parameter estimation and variable selection.
  • Incorporating interaction terms into these models presents a significant computational challenge.

Purpose of the Study:

  • To develop and evaluate methods for incorporating interaction terms in high-dimensional time-to-event prediction models.
  • To address the computational expense of evaluating all possible interactions.

Main Methods:

  • Utilized a boosting technique for effect estimation.
  • Employed building blocks for interaction pre-selection: resampling, random forests, and orthogonalization.
  • Conducted simulation studies and analyzed real-world data.

Main Results:

  • The combined strategy effectively detected true main effects and interactions across various scenarios.
  • Identified challenges in detecting interactions not represented by main effects, but showed promising results.
  • Real-world data indicated that interaction effect sizes may not always be sufficient to enhance prediction performance despite biological relevance.

Conclusions:

  • Screening interactions using random forests is a feasible and valuable approach for identifying relevant two-way interactions.
  • Resampling, random forests, and orthogonalization significantly enhance interaction pre-selection.
  • Defined the limits of interaction detection based on necessary effect sizes, highlighting the need to leverage existing and new methods.